Discover 3,086 paid clinical trials in Worcester, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,086
Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions
for
Pancreatic Cyst
Location: Boston MA, New Haven CT, Garden City NY, New York NY,
Sponsor: Ohio State University Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT03492151
Recruiting
Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer
for
Anatomic Stage III Breast Cancer AJCC v8,
Location: Boston MA, Mineola NY, New York NY, Columbus OH,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05422794
Phase 1, Recruiting
Pharmacological Activation of HMN for OSA Aim 2
for
Obstructive Sleep Apnea
Location: Boston MA
Sponsor: Brigham and Women's Hospital
Sex: All
Age: 18 - 70
Code: NCT03858751
Phase 1, Phase 2, Recruiting
ELEVATE-MM: Elotuzumab, Iberdomide and Dexamethasone Post Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
ViTAA Registry Pre- and Post-Operative Monitoring for Endovascular Aortic Aneurysm Repair and Serial Monitoring for AAA
for
Abdominal Aortic Aneurysms
Location: Boston MA, Montreal, Toronto, Chapel Hill NC,
Sponsor: ViTAA Medical Solutions
Sex: All
Age: 18+
Code: NCT05004051
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer
for
Advanced Breast Cancer
Location: Boston MA, Stony Brook NY, Mineola NY, New York NY,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06380751
Phase 3, Recruiting
Observational Study Protocol: LIVER-R
for
Hepatobiliary Cancers
Location: Boston MA, White Plains NY, Bethlehem PA,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06252753
Recruiting
Necrosectomy With Cryotechnology for Accelerated Removal
for
Pancreatic Necrosis, Acute Pancreatitis,
Location: Boston MA
Sponsor: Christopher C. Thompson, MD, MSc
Sex: All
Age: 18+
Code: NCT06553651
Recruiting
Chromatic Pupillometry to Assess the Melanopsin-Light Pathway in Progressive Supranuclear Palsy
Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps
Location: Boston MA, Philadelphia PA, Toronto, Virginia City VA,
Sponsor: The European Forum for Research and Education in Allergy and Airway Diseases
Sex: All
Age: 18+
Code: NCT06970977
Recruiting
Texting to Reduce Human Immunodeficiency Virus (HIV) Risk
for
HIV Infections
Location: Boston MA
Sponsor: Boston University
Sex: All
Age: 18+
Code: NCT06088277
Recruiting
Evaluating Interventions for Intimate Partner Violence Use in Washington State
for
Intimate Partner Violence
Location: Boston MA
Sponsor: Boston University
Sex: All
Age: 18+
Code: NCT06526247
Recruiting
Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers
for
Metastatic Salivary Gland Carcinoma,
Location: Boston MA, Lebanon NH, Commack NY, Harrison NY,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT05408845
Phase 2, Recruiting
Molecular Imaging of Primary Amyloid Cardiomyopathy
for
Amyloidosis, Primary, Cardiomyopathy
Location: Boston MA
Sponsor: Brigham and Women's Hospital
Sex: All
Age: 18 - 70+
Code: NCT02641145
Recruiting
Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer
A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma
for
Glioblastoma, Recurrent Glioblastoma, Brain Tumor
Location: Boston MA
Sponsor: Ugonma Chukwueke
Sex: All
Age: 18+
Code: NCT06552260
Early Phase 1, Recruiting
A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors